Revenue growth has trended into negative territory with a 3.6% year-over-year decline in 2026Q1, despite the company maintaining a robust gross margin profile of 78.4%.
| Metric | TTM | Nov'25 | Nov'24 | Nov'23 | Nov'22 | Nov'21 | Nov'20 | Nov'19 | Nov'18 | Nov'17 | Nov'16 | Nov'15 | Nov'14 | Nov'13 | Nov'12 | Nov'11 | Nov'10 | Nov'09 | Nov'08 | Nov'07 | Nov'06 | Nov'05 | Nov'04 | Nov'03 | Nov'02 | Nov'01 | Nov'00 | Nov'99 | Nov'98 | Nov'97 | Nov'96 |
|---|
| Sales/Revenue | 31.28M | 31.57M | 31.99M | 31.34M | 30.34M | 28.88M | 31.15M | 31.82M | 29.22M | 25.38M | 23.13M | 21.09M | 20.13M | 18.99M | 17.97M | 17.92M | 17.64M | 16.33M | 17.28M | 17.46M | 17.18M | 14.45M | 12.21M | 7.55M | 7.07M | 5.65M | 2.11M | 1.7M | 300K | 400K | 2.7M |
| Revenue Growth % | -2.56% | -1.31% | 2.05% | 3.32% | 5.03% | -7.26% | -2.1% | 8.89% | 15.1% | 9.76% | 9.66% | 4.79% | 5.96% | 5.7% | 0.29% | 1.58% | 8.04% | -5.51% | -1.04% | 1.63% | 18.88% | 18.35% | 61.74% | 6.74% | 25.22% | 167.78% | 24.08% | 466.67% | -25% | -85.19% | - |
| Cost of Goods Sold | 7.05M | 7.38M | 7.95M | 8.44M | 8.79M | 8.99M | 9.66M | 10.04M | 8.54M | 6.72M | 5.77M | 5.63M | 5.63M | 5.32M | 4.89M | 4.4M | 4.5M | 4.53M | 6.11M | 6.59M | 6.07M | 4.14M | 3.16M | 2.63M | 2.5M | 1.66M | 827.33K | 200K | 200K | 0 | 300K |
| COGS % of Revenue | - | 23.37% | 24.85% | 26.93% | 28.98% | 31.12% | 31.01% | 31.54% | 29.23% | 26.49% | 24.97% | 26.7% | 27.98% | 28.02% | 27.2% | 24.55% | 25.54% | 27.76% | 35.38% | 37.76% | 35.32% | 28.67% | 25.9% | 34.77% | 35.28% | 29.32% | 39.22% | 11.76% | 66.67% | - | 11.11% |
| Gross Profit | 24.23M | 24.19M | 24.04M | 22.9M | 21.54M | 19.9M | 21.49M | 21.78M | 20.68M | 18.66M | 17.35M | 15.46M | 14.49M | 13.67M | 13.08M | 13.52M | 13.13M | 11.79M | 11.16M | 10.87M | 11.11M | 10.31M | 9.05M | 4.92M | 4.58M | 3.99M | 1.28M | 1.5M | 100K | 400K | 2.4M |
| Gross Margin % | 77.47% | 76.63% | 75.15% | 73.07% | 71.02% | 68.88% | 68.99% | 68.46% | 70.77% | 73.51% | 75.03% | 73.3% | 72.02% | 71.98% | 72.8% | 75.45% | 74.46% | 72.24% | 64.62% | 62.24% | 64.68% | 71.33% | 74.1% | 65.23% | 64.72% | 70.68% | 60.78% | 88.24% | 33.33% | 100% | 88.89% |
| Gross Profit Growth % | - | 0.63% | 4.96% | 6.3% | 8.29% | -7.42% | -1.33% | 5.33% | 10.82% | 7.53% | 12.24% | 6.67% | 6.01% | 4.52% | -3.24% | 2.93% | 11.37% | 5.64% | 2.73% | -2.2% | 7.8% | 13.94% | 83.72% | 7.57% | 14.67% | 211.42% | -14.53% | 1400% | -75% | -83.33% | - |
| Operating Expenses | 24.04M | 19.35M | 20.56M | 35.21M | 17.52M | 15.88M | 13.83M | 16.72M | 15.49M | 13.65M | 16.92M | 12.53M | 12.51M | 11.97M | 14.79M | 13.8M | 9.91M | 10.12M | 11.49M | 15.54M | 14.07M | 9.08M | 5.87M | 12.45M | 10.12M | 4.48M | 3.44M | 2.5M | 2.5M | 2.1M | 1.6M |
| OpEx % of Revenue | - | 61.29% | 64.27% | 112.32% | 57.75% | 54.97% | 44.4% | 52.54% | 53.01% | 53.79% | 73.16% | 59.4% | 62.17% | 63.02% | 82.32% | 76.99% | 56.19% | 62% | 66.51% | 89.01% | 81.91% | 62.86% | 48.06% | 164.87% | 143.01% | 79.28% | 163.23% | 147.06% | 833.33% | 525% | 59.26% |
| Selling, General & Admin | 18.59M | 18.22M | 18.52M | 17.12M | 15.58M | 14.63M | 14.29M | 14.89M | 15.63M | 13.48M | 14.72M | 12.39M | 12.25M | 11.37M | 14.43M | 12.41M | 9.49M | 8.94M | 10.83M | 14.46M | 12.96M | 9.1M | 6.27M | 9.71M | 6.06M | 3.95M | 2.85M | 2.3M | 1.9M | 1.8M | 1.5M |
| SG&A % of Revenue | - | 57.72% | 57.9% | 54.61% | 51.36% | 50.63% | 45.89% | 46.8% | 53.5% | 53.11% | 63.66% | 58.74% | 60.87% | 59.84% | 80.28% | 69.28% | 53.77% | 54.74% | 62.67% | 82.83% | 75.42% | 63% | 51.38% | 128.65% | 85.62% | 69.94% | 135.29% | 135.29% | 633.33% | 450% | 55.56% |
| Research & Development | 343.88K | 376.26K | 1.24M | 1.17M | 384.79K | 49.87K | 23.85K | 30.14K | 91.84K | 41.16K | 53.1K | 45.78K | 64.37K | 36.17K | 109.64K | 184.05K | 132.99K | 102.41K | 194.46K | 545.49K | 486.16K | 26.15K | 82.51K | 226.68K | 219.66K | 51.07K | 275.8K | 100K | 400K | 200K | 0 |
| R&D % of Revenue | - | 1.19% | 3.88% | 3.74% | 1.27% | 0.17% | 0.08% | 0.09% | 0.31% | 0.16% | 0.23% | 0.22% | 0.32% | 0.19% | 0.61% | 1.03% | 0.75% | 0.63% | 1.13% | 3.12% | 2.83% | 0.18% | 0.68% | 3% | 3.11% | 0.9% | 13.08% | 5.88% | 133.33% | 50% | - |
| Other Operating Expenses | 1.56M | 751.47K | 794.32K | 16.92M | 1.55M | 1.22M | -489.53K | 1.8M | -235.02K | 131.61K | 2.14M | 92.11K | 196.98K | 566.97K | 256.69K | 1.2M | 294.06K | 1.08M | 469.5K | 532.31K | 629.15K | -45.87K | -488.89K | 2.51M | 3.84M | 476.48K | 313.49K | 100K | 200K | 100K | 100K |
| Operating Income | 191.52K | 4.84M | 3.48M | -12.3M | 4.02M | 4.02M | 7.66M | 5.06M | 5.19M | 5.01M | 433.59K | 2.93M | 1.98M | 1.7M | -1.71M | -276.74K | 3.22M | 1.67M | -326.75K | -4.67M | -2.96M | 1.22M | 3.18M | -7.52M | -5.54M | -485.89K | -2.16M | -1M | -2.4M | -1.7M | 800K |
| Operating Margin % | 0.61% | 15.34% | 10.88% | -39.26% | 13.27% | 13.91% | 24.6% | 15.91% | 17.76% | 19.72% | 1.87% | 13.91% | 9.84% | 8.96% | -9.52% | -1.54% | 18.27% | 10.24% | -1.89% | -26.76% | -17.23% | 8.47% | 26.04% | -99.64% | -78.28% | -8.6% | -102.45% | -58.82% | -800% | -425% | 29.63% |
| Operating Income Growth % | - | 39.1% | 128.29% | -405.73% | 0.16% | -47.55% | 51.33% | -2.44% | 3.66% | 1054.59% | -85.22% | 48.05% | 16.35% | 199.51% | -518.31% | -108.59% | 92.69% | 611.79% | 93.01% | -57.86% | -341.84% | -61.51% | 142.27% | -35.86% | -1039.57% | 77.52% | -116.11% | 58.33% | -41.18% | -312.5% | - |
| EBITDA | 1.55M | 6.21M | 3.96M | -10.59M | 5.83M | 5.34M | 8.3M | 5.46M | 5.51M | 5.24M | 720.24K | 3.17M | 2.36M | 2.1M | -1.24M | 303.11K | 3.8M | 2.34M | 351.4K | -3.93M | -2.24M | 1.82M | 3.84M | -7.07M | -4.73M | 26.74K | -1.85M | -900K | -2.2M | -1.6M | 900K |
| EBITDA Margin % | 4.95% | 19.67% | 12.39% | -33.8% | 19.23% | 18.5% | 26.64% | 17.17% | 18.85% | 20.63% | 3.11% | 15.05% | 11.72% | 11.04% | -6.92% | 1.69% | 21.56% | 14.36% | 2.03% | -22.51% | -13.01% | 12.6% | 31.42% | -93.65% | -66.94% | 0.47% | -87.59% | -52.94% | -733.33% | -400% | 33.33% |
| EBITDA Growth % | -68.52% | 56.65% | 137.42% | -281.59% | 9.15% | -35.59% | 51.86% | -0.77% | 5.16% | 627.01% | -77.31% | 34.61% | 12.44% | 268.54% | -510.55% | -92.03% | 62.22% | 567.06% | 108.94% | -75.84% | -222.74% | -52.53% | 154.27% | -49.33% | -17806.71% | 101.45% | -105.28% | 59.09% | -37.5% | -277.78% | - |
| D&A (Non-Cash Add-back) | 1.36M | 1.37M | 483.52K | 1.71M | 1.81M | 1.33M | 635.98K | 401.31K | 317.33K | 230K | 286.65K | 241.21K | 377.01K | 394.5K | 466.74K | 579.85K | 580.19K | 671.82K | 678.15K | 741.77K | 724.52K | 597.37K | 657.38K | 452.58K | 802.45K | 512.63K | 313.49K | 100K | 200K | 100K | 100K |
| EBIT | -766.56K | -270.9K | 939.44K | -12.13M | 4.84M | 3.99M | 6.58M | 5.09M | 5.16M | 4.93M | -1.53M | 2.25M | 1.83M | 1.6M | -3.4M | -466.85K | 3.37M | 2.96M | 700.7K | -4.67M | -2.96M | 1.22M | 3.18M | -6.78M | -5.96M | -485.89K | -2.16M | -1M | -2.2M | -1.5M | 800K |
| Net Interest Income | -2.03M | -2.07M | -1.86M | -1.24M | -1.52M | -1.38M | -1.54M | -1.7M | -1.55M | -1.3M | -947.34K | -1.3M | -1.15M | -1.4M | -1.02M | -1.46M | -1.26M | -1.34M | -1.17M | -1.07M | -693.02K | -720.22K | -702.62K | -602.49K | 69.42K | 100.28K | 119.62K | 0 | -100K | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.3K | 71.64K | 154.82K | 318.01K | 322.37K | 143.5K | 47.51K | 53.24K | 128.27K | 110.77K | 121.83K | 0 | 0 | 0 | 0 |
| Interest Expense | 2.03M | 2.07M | 1.86M | 1.24M | 1.52M | 1.38M | 1.54M | 1.7M | 1.55M | 1.3M | 947.34K | 1.3M | 1.15M | 1.4M | 1.02M | 1.46M | 1.28M | 1.42M | 1.32M | 1.39M | 1.02M | 863.71K | 750.13K | 655.73K | 58.85K | 10.48K | 2.21K | 0 | 100K | 0 | 0 |
| Other Income/Expense | -2.99M | -7.18M | -676.16K | -1.06M | -705.52K | -1.41M | -2.62M | -1.67M | -1.57M | -1.38M | -2.91M | -1.98M | 0 | 0 | -2.71M | -1.42M | -1.26M | -12.97K | -269.34K | -332.75K | 232.98K | -106.79K | -160.71K | 1.07K | 209.56K | 485.89K | 2.16M | 1M | 2.2M | 100K | -800K |
| Pretax Income | -2.8M | -2.34M | 2.8M | -13.36M | 3.32M | 2.61M | 5.04M | 3.39M | 3.62M | 3.62M | -2.48M | 949.52K | 677.15K | 197.02K | -4.42M | -1.7M | 1.78M | 1.55M | -760.42K | -5.01M | -2.73M | 1.12M | 3.02M | -7.52M | -5.17M | 775.95K | -1.61M | -500K | 0 | -1.6M | 700K |
| Pretax Margin % | -8.95% | -7.4% | 8.77% | -42.64% | 10.94% | 9.04% | 16.18% | 10.66% | 12.38% | 14.28% | -10.72% | 4.5% | 3.36% | 1.04% | -24.6% | -9.47% | 10.09% | 9.47% | -4.4% | -28.67% | -15.87% | 7.73% | 24.72% | -99.62% | -73.04% | 13.74% | -76.34% | -29.41% | - | -400% | 25.93% |
| Income Tax | -135.43K | 92.23K | 2.4M | -3.84M | 547.54K | 527.71K | 1.41M | 1.1M | 4.47M | 1.31M | -1.16M | -7.16M | 123.53K | 169.58K | 1.89M | 171.94K | -1.63M | 121.81K | 494.41K | 0 | -148.7K | -36K | 86K | 1.1K | 161.5K | -1.39M | -670.37K | -400K | -100K | 0 | 200K |
| Effective Tax Rate % | 4.84% | -3.95% | 85.66% | 28.75% | 16.5% | 20.21% | 28.07% | 32.45% | 123.63% | 36.11% | 46.75% | -753.73% | 18.24% | 86.07% | -42.72% | -10.13% | -91.54% | 7.88% | -65.02% | 0% | 5.45% | -3.22% | 2.85% | -0.01% | -3.13% | -178.56% | 41.63% | 80% | - | 0% | 28.57% |
| Net Income | -2.67M | -2.43M | 402.1K | -9.52M | 2.77M | 2.08M | 3.62M | 2.29M | -854.82K | 2.32M | -1.32M | 8.11M | 553.62K | 27.44K | -6.31M | -2.1M | 3.41M | 1.42M | -760.42K | -5.01M | -2.81M | 1.03M | 2.84M | -7.52M | -5.33M | 899.63K | -1.49M | -600K | -2.3M | -1.6M | 600K |
| Net Margin % | -8.52% | -7.7% | 1.26% | -30.38% | 9.14% | 7.21% | 11.64% | 7.2% | -2.93% | 9.12% | -5.71% | 38.43% | 2.75% | 0.14% | -35.11% | -11.69% | 19.34% | 8.73% | -4.4% | -28.67% | -16.36% | 7.15% | 23.26% | -99.63% | -75.32% | 15.93% | -70.67% | -35.29% | -766.67% | -400% | 22.22% |
| Net Income Growth % | -2170.66% | -704.18% | 104.22% | -443.57% | 33.02% | -42.52% | 58.23% | 367.98% | -136.92% | 275.28% | -116.29% | 1364.24% | 1917.87% | 100.43% | -201.04% | -161.44% | 139.39% | 287.36% | 84.81% | -78.04% | -372.05% | -63.62% | 137.76% | -41.19% | -692.18% | 160.35% | -148.45% | 73.91% | -43.75% | -366.67% | - |
| Net Income (Continuing) | -2.67M | -2.43M | 402.1K | -9.52M | 2.77M | 2.08M | 3.62M | 2.29M | -854.82K | 2.32M | -1.32M | 8.11M | 553.62K | 27.44K | -6.31M | -2.1M | 3.46M | 1.42M | -456.74K | -5.01M | -2.81M | 1.03M | 2.93M | -6.83M | -6.05M | 899.63K | -1.49M | -600K | -2.3M | -1.6M | 600K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 298.39K | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.33 | -0.30 | 0.05 | -1.14 | 0.33 | 0.25 | 0.45 | 0.27 | -0.11 | 0.30 | -0.16 | 0.83 | 0.05 | 0.00 | -0.56 | -0.18 | 0.29 | 0.12 | -0.06 | -0.43 | -0.24 | 0.08 | 0.24 | -0.66 | -0.47 | 0.09 | -0.15 | -0.07 | -0.32 | -0.23 | 0.09 |
| EPS Growth % | -3300% | -700% | 104.39% | -445.45% | 32% | -44.44% | 66.67% | 345.45% | -136.67% | 287.5% | -119.28% | 1560% | - | 100.45% | -211.11% | -162.07% | 141.67% | 284.9% | 84.91% | -79.17% | -400% | -66.67% | 136.36% | -40.43% | -622.22% | 160% | -105.2% | 77.16% | -39.13% | -355.56% | - |
| EPS (Basic) | - | -0.30 | 0.05 | -1.14 | 0.33 | 0.26 | 0.48 | 0.29 | -0.11 | 0.33 | -0.16 | 0.85 | 0.05 | 0.00 | -0.56 | -0.18 | 0.29 | 0.12 | -0.06 | -0.43 | -0.24 | 0.09 | 0.25 | -0.66 | -0.47 | 0.09 | -0.15 | -0.07 | -0.32 | -0.23 | 0.09 |
| Diluted Shares Outstanding | 8.06M | 8.07M | 8.21M | 8.34M | 8.48M | 8.36M | 8.14M | 8.41M | 7.46M | 7.65M | 8.11M | 9.8M | 10.43M | 10.97M | 11.31M | 11.76M | 11.81M | 11.8M | 11.73M | 11.66M | 11.62M | 12.23M | 11.91M | 11.35M | 11.34M | 10.58M | 9.76M | 8.21M | 7.28M | 6.96M | 7.18M |
| Basic Shares Outstanding | 8.06M | 8.07M | 8.13M | 8.34M | 8.47M | 8.14M | 8.14M | 8.41M | 7.46M | 7.06M | 8.11M | 9.54M | 10.18M | 10.86M | 11.31M | 11.76M | 11.75M | 11.75M | 11.73M | 11.66M | 11.62M | 11.58M | 11.37M | 11.35M | 11.34M | 10.58M | 9.76M | 8.21M | 7.28M | 6.96M | 7.18M |
| Dividend Payout Ratio | - | - | 502.5% | - | 276.85% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Liquidity and enrollment stagnation
According to the latest quarterly financial disclosures, CCEL's revenue growth has trended into negative territory, with the most recent period showing a 3.6% year-over-year decline, suggesting that the company's core customer acquisition engine is struggling to maintain momentum in a competitive and discretionary healthcare market.
The consistent deceleration from positive growth in early 2024 to current contraction indicates that the company is failing to offset churn with new enrollments. This trend suggests that the firm's reliance on birth-rate-sensitive demand is becoming a structural liability rather than a stable annuity base.
As reported in recent income statements, CCEL maintains a robust gross margin profile averaging approximately 76%, which highlights the inherent scalability of its cryogenic storage infrastructure despite the broader operational challenges currently impacting the company's bottom-line profitability and overall financial health.
While the gross margin remains high, the significant gap between these figures and the erratic operating margins suggests that the company is struggling to control its overhead costs. Investors should monitor whether these high gross margins can be sustained if competitive pricing pressures force a reduction in service fees.
Based on the provided financial data, CCEL's operating leverage appears severely compromised, as SG&A expenses frequently fluctuate in a manner that disproportionately impacts operating income, leading to inconsistent profitability and a reliance on non-operating items to stabilize the company's quarterly net income results.
The inability to consistently scale operating income alongside gross profit suggests that the company's administrative and marketing expenses are not optimized for its current revenue level. This lack of operating leverage may indicate that the firm is overspending on customer acquisition relative to the lifetime value of the contracts secured.
Analysis of the company's cost structure reveals that SG&A remains the primary driver of earnings volatility, with quarterly expenditures often exceeding $5 million, which significantly outweighs the company's ability to generate consistent operating income from its core storage and processing service revenue streams.
The erratic nature of SG&A spending suggests a lack of rigorous expense discipline, which is particularly concerning given the company's thin cash position. Management appears to be struggling to balance the necessary investment in clinical partnerships with the need to maintain a lean operational footprint.
Data from recent filings indicates that CCEL's cash reserves have dwindled to approximately $319,031, a precarious level that may force management to seek dilutive financing or debt to sustain its ongoing clinical-stage investments and daily operations in the face of persistent revenue contraction.
Short-sellers would likely focus on this liquidity crunch as a primary catalyst for future equity dilution. The company's pivot toward clinical-stage development appears increasingly risky when the core business is unable to generate sufficient free cash flow to fund its own strategic ambitions.
Quick answers to the most common questions about buying CCEL stock.
For fiscal year 2025, Cryo-Cell International, Inc. (CCEL) reported total revenue of $31.6M. This represents a 1069.1% increase compared to $2.7M in 1996.
Cryo-Cell International, Inc. (CCEL) reported a net loss of $2.4M for the fiscal year ending 2025.
Cryo-Cell International, Inc. (CCEL) reported an operating income of $4.8M, resulting in an operating profit margin of 15.3%. This margin reflects the operational efficiency of the business before interest and taxes.
Cryo-Cell International, Inc. (CCEL) generated $24.2M in gross profit for the year, representing a gross profit margin of 76.6%. This demonstrates the company's core pricing power and production efficiency.